{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:23:16Z","timestamp":1790126596291,"version":"4.0.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic research project of Shenzhen Science and Technology Planning Project","award":["JCYJ20220530155611026"],"award-info":[{"award-number":["JCYJ20220530155611026"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202311027"],"award-info":[{"award-number":["SZSM202311027"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Key Specialty Construction Project of Guangdong Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Intake of nutrients and water from diet to maintain life, a typical physiological function of gut, is highly dependent on the extensive immune network, whose imbalance is easy to induce inflammatory bowel disease (IBD) including Crohn\u2019s disease (CD) and ulcerative colitis (UC). Clinical strategies to completely cure IBD are poor, so it is urgent to develop novel drugs or targets. Adiponectin (APN), an adipokine from adipocytes, regulates energy metabolism and immune response. High levels APN are inversely associated with CD severity UC colonic fibrosis. However, the mechanism by which APN interferes with IBD remains unclear. This review aims to analyze correlation and molecular mechanism between APN and IBD. APN and AdipoR2 proteins are highly expressed in colon which is a primary organ of IBD, and the target intersection of APN and IBD is huge. APN may interfere with lipid metabolism in IBD individuals through AdipoR1\/2, but regulates neural and peripheral immune by AdipoR1 but not AdipoR2 and mediates nutritional and energy homeostasis through AdipoR2 rather than AdipoR1. Besides, APN mediates CRP and IL-6 through AdipoR1\/2, AMPK and TNF-\u03b1 through AdipoR1 and PI3K-Akt, PPARA and PPARG through AdipoR2 to affect IBD progression, which depends on direct interaction between APPL1 and AdipoR1\/2. Unexpectedly, AMPK and TNF-\u03b1 may also interact directly with AdipoR1. APN regulates CD through AdipoR1\/2-metabolism process and UC through AdipoR1-inflammation axis or AdipoR2-fibrosis process. APN analogues or AdipoRon which is a dual agonist of AdipoR1\/2 potentially reduces colonic fibrosis in UC and fistulae in CD, promotes mucosal healing, repairs intestinal microbiota homeostasis and increases autophagy to alleviate IBD symptoms by weakening TNF-\u03b1, IL-6, NLRP3, TGFB1 activities and aggrandizing P-AKT, PPARA, PPARG, INS, IRS1\/2, IGF-1, TIMP1, NOD2, SIRT1 levels.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphic Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1186\/s12964-025-02359-w","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:45:04Z","timestamp":1753519504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Role of adiponectin and its receptors AdipoR1\/2 in inflammatory bowel disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Qiuyan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"2359_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14:667\u201385. https:\/\/doi.org\/10.1038\/nri3738.","journal-title":"Nat Rev Immunol"},{"key":"2359_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty LM, Jones G-R, Bain CC. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat Reviews Gastroenterol Hepatol. 2023;20:538\u201353. https:\/\/doi.org\/10.1038\/s41575-023-00769-0.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2359_CR3","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","volume":"178","author":"JC Martin","year":"2019","unstructured":"Martin JC, et al. Single-Cell analysis of crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to Anti-TNF therapy. Cell. 2019;178:1493\u2013e15081420. https:\/\/doi.org\/10.1016\/j.cell.2019.08.008.","journal-title":"Cell"},{"key":"2359_CR4","doi-asserted-by":"publisher","unstructured":"Peng Y-J, et al. Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease. J Biomed Sci. 2018;25. https:\/\/doi.org\/10.1186\/s12929-018-0419-3.","DOI":"10.1186\/s12929-018-0419-3"},{"key":"2359_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","volume":"19","author":"TH Bisgaard","year":"2022","unstructured":"Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Reviews Gastroenterol Hepatol. 2022;19:717\u201326. https:\/\/doi.org\/10.1038\/s41575-022-00634-6.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2359_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161:1118\u201332. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.042.","journal-title":"Gastroenterology"},{"key":"2359_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s2468-1253(21)00014-5","volume":"6","author":"B Barberio","year":"2021","unstructured":"Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:359\u201370. https:\/\/doi.org\/10.1016\/s2468-1253(21)00014-5.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2359_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2020","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Reviews Gastroenterol Hepatol. 2020;18:56\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00360-x.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2359_CR9","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/s0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378. https:\/\/doi.org\/10.1016\/s0140-6736(17)32448-0.","journal-title":"Lancet"},{"key":"2359_CR10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","volume":"156","author":"S Coward","year":"2019","unstructured":"Coward S, et al. Past and future burden of inflammatory bowel diseases based on modeling of Population-Based data. Gastroenterology. 2019;156:1345\u2013e13531344. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.002.","journal-title":"Gastroenterology"},{"key":"2359_CR11","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1136\/gutjnl-2019-318936","volume":"68","author":"G-R Jones","year":"2019","unstructured":"Jones G-R, et al. IBD prevalence in lothian, scotland, derived by capture\u2013recapture methodology. Gut. 2019;68:1953\u201360. https:\/\/doi.org\/10.1136\/gutjnl-2019-318936.","journal-title":"Gut"},{"key":"2359_CR12","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1053\/j.gastro.2022.01.024","volume":"162","author":"N Plevris","year":"2022","unstructured":"Plevris N, Lees CW. Disease monitoring in inflammatory bowel disease: evolving principles and possibilities. Gastroenterology. 2022;162:1456\u2013e14751451. https:\/\/doi.org\/10.1053\/j.gastro.2022.01.024.","journal-title":"Gastroenterology"},{"key":"2359_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/gutjnl-2012-303034","volume":"62","author":"AL Cava","year":"2013","unstructured":"Cava AL. Adiponectin: a relevant player in obesity-related colorectal cancer? Gut. 2013;62:483\u20134. https:\/\/doi.org\/10.1136\/gutjnl-2012-303034.","journal-title":"Gut"},{"key":"2359_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","volume":"121","author":"G Fantuzzi","year":"2008","unstructured":"Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol. 2008;121:326\u201330. https:\/\/doi.org\/10.1016\/j.jaci.2007.10.018.","journal-title":"J Allergy Clin Immunol"},{"key":"2359_CR15","first-page":"1169","volume":"58","author":"X-F Huang","year":"2009","unstructured":"Huang X-F, Chen J. Adiponectin and signal pathways in obesity-induced colon cancer. Gut. 2009;58:1169.","journal-title":"Gut"},{"key":"2359_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1053\/j.gastro.2006.06.015","volume":"131","author":"T Nishihara","year":"2006","unstructured":"Nishihara T, et al. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology. 2006;131:853\u201361. https:\/\/doi.org\/10.1053\/j.gastro.2006.06.015.","journal-title":"Gastroenterology"},{"key":"2359_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.12.032","author":"H Xiao","year":"2024","unstructured":"Xiao H, et al. Adiponectin deficiency prevents chronic colitis-associated colonic fibrosis via inhibiting CXCL13 production. J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.12.032.","journal-title":"J Adv Res"},{"key":"2359_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/gut.2004.046516","volume":"54","author":"K Yamamoto","year":"2005","unstructured":"Yamamoto K. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in crohn\u2019s disease. Gut. 2005;54:789\u201396. https:\/\/doi.org\/10.1136\/gut.2004.046516.","journal-title":"Gut"},{"issue":"e681","key":"2359_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cgh.2011.05.005","volume":"9","author":"B Erhayiem","year":"2011","unstructured":"Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V. Ratio of visceral to subcutaneous fat area is a biomarker of complicated crohn\u2019s disease. Clin Gastroenterol Hepatol. 2011;9(e681):684\u20137. https:\/\/doi.org\/10.1016\/j.cgh.2011.05.005.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2359_CR20","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/gutjnl-2011-301424","volume":"62","author":"LI Kredel","year":"2013","unstructured":"Kredel LI, et al. Adipokines from local fat cells shape the macrophage compartment of the creeping fat in crohn\u2019s disease. Gut. 2013;62:852\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2011-301424.","journal-title":"Gut"},{"key":"2359_CR21","doi-asserted-by":"publisher","first-page":"G591","DOI":"10.1152\/ajpgi.00269.2014","volume":"308","author":"A Sideri","year":"2015","unstructured":"Sideri A, et al. Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1. Am J Physiology-Gastrointestinal Liver Physiol. 2015;308:G591\u2013604. https:\/\/doi.org\/10.1152\/ajpgi.00269.2014.","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"2359_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1136\/gut.2008.159293","volume":"57","author":"T Fujisawa","year":"2008","unstructured":"Fujisawa T, et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut. 2008;57:1531\u20138. https:\/\/doi.org\/10.1136\/gut.2008.159293.","journal-title":"Gut"},{"key":"2359_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1053\/j.gastro.2006.11.026","volume":"132","author":"R Fayad","year":"2007","unstructured":"Fayad R, et al. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology. 2007;132:601\u201314. https:\/\/doi.org\/10.1053\/j.gastro.2006.11.026.","journal-title":"Gastroenterology"},{"key":"2359_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cytogfr.2011.04.002","volume":"22","author":"EK Tiaka","year":"2011","unstructured":"Tiaka EK, Manolakis AC, Kapsoritakis AN, Potamianos SP. The implication of adiponectin and resistin in Gastrointestinal diseases. Cytokine Growth Factor Rev. 2011;22:109\u201319. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.04.002.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2359_CR25","doi-asserted-by":"crossref","unstructured":"Fisman EZ, Tenenbaum A. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol 13 (2014).","DOI":"10.1186\/1475-2840-13-103"},{"key":"2359_CR26","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.cgh.2015.02.037","volume":"13","author":"KB Greer","year":"2015","unstructured":"Greer KB, Falk GW, Bednarchik B, Li L, Chak A. Associations of serum adiponectin and leptin with barrett\u2019s esophagus. Clin Gastroenterol Hepatol. 2015;13:2265\u201372. https:\/\/doi.org\/10.1016\/j.cgh.2015.02.037.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2359_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.metabol.2014.02.001","volume":"63","author":"KK Vetvik","year":"2014","unstructured":"Vetvik KK, et al. Globular adiponectin and its downstream target genes are up-regulated locally in human colorectal tumors: ex vivo and in vitro studies. Metabolism. 2014;63:672\u201381. https:\/\/doi.org\/10.1016\/j.metabol.2014.02.001.","journal-title":"Metabolism"},{"key":"2359_CR28","doi-asserted-by":"publisher","unstructured":"Mutoh M et al. Loss of Adiponectin Promotes Intestinal Carcinogenesis in Min and Wild-type Mice. Gastroenterology 140, 2000\u20132008.e2002, https:\/\/doi.org\/10.1053\/j.gastro.2011.02.019 (2011).","DOI":"10.1053\/j.gastro.2011.02.019"},{"key":"2359_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nm1557","volume":"13","author":"T Yamauchi","year":"2007","unstructured":"Yamauchi T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007;13:332\u20139. https:\/\/doi.org\/10.1038\/nm1557.","journal-title":"Nat Med"},{"key":"2359_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439\u201351. https:\/\/doi.org\/10.1210\/er.2005-0005.","journal-title":"Endocr Rev"},{"key":"2359_CR31","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nature01683","volume":"423","author":"I Kovalchuk","year":"2003","unstructured":"Kovalchuk I, et al. Pathogen-induced systemic plant signal triggers DNA rearrangements. Nature. 2003;423:760\u20132. https:\/\/doi.org\/10.1038\/nature01683.","journal-title":"Nature"},{"key":"2359_CR32","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm788","volume":"8","author":"T Yamauchi","year":"2002","unstructured":"Yamauchi T, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288\u201395. https:\/\/doi.org\/10.1038\/nm788.","journal-title":"Nat Med"},{"key":"2359_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/cr.2009.39","volume":"19","author":"T Fiaschi","year":"2009","unstructured":"Fiaschi T, et al. Globular adiponectin induces differentiation and fusion of skeletal muscle cells. Cell Res. 2009;19:584\u201397. https:\/\/doi.org\/10.1038\/cr.2009.39.","journal-title":"Cell Res"},{"key":"2359_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-018-0026-1","volume":"556","author":"K-C Pao","year":"2018","unstructured":"Pao K-C, et al. Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. Nature. 2018;556:381\u20135. https:\/\/doi.org\/10.1038\/s41586-018-0026-1.","journal-title":"Nature"},{"key":"2359_CR35","doi-asserted-by":"publisher","unstructured":"Kiss L, Clift D, Renner N, Neuhaus D, James LC. RING domains act as both substrate and enzyme in a catalytic arrangement to drive self-anchored ubiquitination. Nat Commun. 2021;12. https:\/\/doi.org\/10.1038\/s41467-021-21443-6.","DOI":"10.1038\/s41467-021-21443-6"},{"key":"2359_CR36","doi-asserted-by":"publisher","unstructured":"Cai C, Tang Y-D, Zhai J, Zheng C. The RING finger protein family in health and disease. Signal Transduct Target Therapy. 2022;7. https:\/\/doi.org\/10.1038\/s41392-022-01152-2.","DOI":"10.1038\/s41392-022-01152-2"},{"key":"2359_CR37","doi-asserted-by":"publisher","unstructured":"Roel-Touris J, Jim\u00e9nez-Garc\u00eda B, Bonvin AMJ. J. Integrative modeling of membrane-associated protein assemblies. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-20076-5.","DOI":"10.1038\/s41467-020-20076-5"},{"key":"2359_CR38","doi-asserted-by":"publisher","first-page":"W331","DOI":"10.1093\/nar\/gkz368","volume":"47","author":"AA Roy","year":"2019","unstructured":"Roy AA, Dhawanjewar AS, Sharma P, Singh G, Madhusudhan MS. Protein interaction Z score assessment (PIZSA): an empirical scoring scheme for evaluation of protein\u2013protein interactions. Nucleic Acids Res. 2019;47:W331\u20137. https:\/\/doi.org\/10.1093\/nar\/gkz368.","journal-title":"Nucleic Acids Res"},{"key":"2359_CR39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2017","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2017;19:121\u201335. https:\/\/doi.org\/10.1038\/nrm.2017.95.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2359_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","volume":"145","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, et al. Class IIa histone deacetylases are Hormone-Activated regulators of FOXO and mammalian glucose homeostasis. Cell. 2011;145:607\u201321. https:\/\/doi.org\/10.1016\/j.cell.2011.03.043.","journal-title":"Cell"},{"key":"2359_CR41","doi-asserted-by":"publisher","unstructured":"He J, et al. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nat Commun. 2021;12. https:\/\/doi.org\/10.1038\/s41467-021-24619-2.","DOI":"10.1038\/s41467-021-24619-2"},{"key":"2359_CR42","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1467-789X.2009.00607.x","volume":"10","author":"XF Huang","year":"2009","unstructured":"Huang XF, Chen JZ. Obesity, the PI3K\/Akt signal pathway and colon cancer. Obes Rev. 2009;10:610\u20136. https:\/\/doi.org\/10.1111\/j.1467-789X.2009.00607.x.","journal-title":"Obes Rev"},{"key":"2359_CR43","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM, et al. PI3K\u03b3 is a molecular switch that controls immune suppression. Nature. 2016;539:437\u201342. https:\/\/doi.org\/10.1038\/nature19834.","journal-title":"Nature"},{"key":"2359_CR44","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.apsb.2022.10.003","volume":"13","author":"N Song","year":"2023","unstructured":"Song N, et al. Synergistic activation of AMPK by AdipoR1\/2 agonist and inhibitor of EDPs\u2013EBP interaction recover NAFLD through enhancing mitochondrial function in mice. Acta Pharm Sinica B. 2023;13:542\u201358. https:\/\/doi.org\/10.1016\/j.apsb.2022.10.003.","journal-title":"Acta Pharm Sinica B"},{"key":"2359_CR45","doi-asserted-by":"publisher","unstructured":"Xu H, et al. AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via Endoplasmic reticulum-mitochondria axis. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-19668-y.","DOI":"10.1038\/s41467-020-19668-y"},{"key":"2359_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature12656","volume":"503","author":"M Okada-Iwabu","year":"2013","unstructured":"Okada-Iwabu M, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature. 2013;503:493\u20139. https:\/\/doi.org\/10.1038\/nature12656.","journal-title":"Nature"},{"key":"2359_CR47","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnae021","author":"I Gianopoulos","year":"2024","unstructured":"Gianopoulos I, Mantzoros CS, Daskalopoulou SS. Adiponectin and adiponectin receptors in atherosclerosis. Endocr Rev. 2024. https:\/\/doi.org\/10.1210\/endrev\/bnae021.","journal-title":"Endocr Rev"},{"key":"2359_CR48","doi-asserted-by":"publisher","unstructured":"Zhang J, et al. MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT. Redox Biol. 2022;56. https:\/\/doi.org\/10.1016\/j.redox.2022.102469.","DOI":"10.1016\/j.redox.2022.102469"},{"key":"2359_CR49","doi-asserted-by":"publisher","unstructured":"Qiao M, Xue T, Zhu Y, Yang J, Hu J. Polysaccharides from Cistanche deserticola mitigate inflammatory bowel disease via modulating intestinal microbiota and SRC\/EGFR\/PI3K\/AKT signaling pathways. Int J Biol Macromol. 2025;308. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142452.","DOI":"10.1016\/j.ijbiomac.2025.142452"},{"key":"2359_CR50","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.apsb.2020.12.014","volume":"11","author":"Q Hu","year":"2021","unstructured":"Hu Q, et al. Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses. Acta Pharm Sinica B. 2021;11:1493\u2013512. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.014.","journal-title":"Acta Pharm Sinica B"},{"key":"2359_CR51","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1111\/bph.15026","volume":"177","author":"X Han","year":"2020","unstructured":"Han X, et al. Myeloid-specific dopamine D2 receptor signalling controls inflammation in acute pancreatitis via inhibiting M1 macrophage. Br J Pharmacol. 2020;177:2991\u20133008. https:\/\/doi.org\/10.1111\/bph.15026.","journal-title":"Br J Pharmacol"},{"key":"2359_CR52","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.metabol.2018.02.004","volume":"85","author":"SR Choi","year":"2018","unstructured":"Choi SR, et al. Adiponectin receptor agonist adiporon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy. Metabolism. 2018;85:348\u201360. https:\/\/doi.org\/10.1016\/j.metabol.2018.02.004.","journal-title":"Metabolism"},{"key":"2359_CR53","doi-asserted-by":"publisher","unstructured":"Liu Y, Fu X, Sun J, Cui R, Yang W. AdipoRon exerts an antidepressant effect by inhibiting NLRP3 inflammasome activation in microglia via promoting mitophagy. Int Immunopharmacol. 2024;141. https:\/\/doi.org\/10.1016\/j.intimp.2024.113011.","DOI":"10.1016\/j.intimp.2024.113011"},{"key":"2359_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1136\/gut.2003.017442","volume":"53","author":"T Kirkegaard","year":"2004","unstructured":"Kirkegaard T, Hansen A, Bruun E, Brynskov J. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with crohn\u2019s disease. Gut. 2004;53:701\u20139. https:\/\/doi.org\/10.1136\/gut.2003.017442.","journal-title":"Gut"},{"key":"2359_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cytogfr.2013.11.001","volume":"25","author":"P Biancheri","year":"2014","unstructured":"Biancheri P, et al. The role of transforming growth factor (TGF)-\u03b2 in modulating the immune response and fibrogenesis in the gut. Cytokine Growth Factor Rev. 2014;25:45\u201355. https:\/\/doi.org\/10.1016\/j.cytogfr.2013.11.001.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2359_CR56","doi-asserted-by":"publisher","unstructured":"Pan Z, et al. Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1086898.","DOI":"10.3389\/fimmu.2023.1086898"},{"key":"2359_CR57","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/gutjnl-2016-313535","volume":"67","author":"G Zhou","year":"2018","unstructured":"Zhou G, et al. CD177\u2009+\u2009neutrophils as functionally activated neutrophils negatively regulate IBD. Gut. 2018;67:1052\u201363. https:\/\/doi.org\/10.1136\/gutjnl-2016-313535.","journal-title":"Gut"},{"key":"2359_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2023.04.001","volume":"203","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, et al. A novel small molecule AdipoR2 agonist ameliorates experimental hepatic steatosis in hamsters and mice. Free Radical Biol Med. 2023;203:69\u201385. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.04.001.","journal-title":"Free Radical Biol Med"},{"key":"2359_CR59","doi-asserted-by":"publisher","first-page":"2403075","DOI":"10.1002\/advs.202403075","volume":"11","author":"E Fu","year":"2024","unstructured":"Fu E, et al. Biomimetic supramolecular assembly with IGF-1\u00a0C delivery ameliorates inflammatory bowel disease (IBD) by restoring intestinal barrier integrity. Adv Sci. 2024;11:2403075. https:\/\/doi.org\/10.1002\/advs.202403075.","journal-title":"Adv Sci"},{"key":"2359_CR60","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nri3608","volume":"14","author":"LW Peterson","year":"2014","unstructured":"Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14:141\u201353. https:\/\/doi.org\/10.1038\/nri3608.","journal-title":"Nat Rev Immunol"},{"key":"2359_CR61","doi-asserted-by":"publisher","first-page":"112239","DOI":"10.1016\/j.biopha.2021.112239","volume":"144","author":"LG Guijarro","year":"2021","unstructured":"Guijarro LG, et al. Relationship between IGF-1 and body weight in inflammatory bowel diseases: cellular and molecular mechanisms involved. Biomed Pharmacother. 2021;144:112239. https:\/\/doi.org\/10.1016\/j.biopha.2021.112239.","journal-title":"Biomed Pharmacother"},{"key":"2359_CR62","doi-asserted-by":"publisher","unstructured":"Geffken SJ, et al. Insulin and IGF-1 elicit robust transcriptional regulation to modulate autophagy in astrocytes. Mol Metabolism. 2022;66. https:\/\/doi.org\/10.1016\/j.molmet.2022.101647.","DOI":"10.1016\/j.molmet.2022.101647"},{"key":"2359_CR63","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee M, Chang EB. Inflammatory bowel diseases (IBD) and the Microbiome\u2014Searching the crime scene for clues. Gastroenterology. 2021;160:524\u201337. https:\/\/doi.org\/10.1053\/j.gastro.2020.09.056.","journal-title":"Gastroenterology"},{"key":"2359_CR64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L, et al. Host\u2013microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119\u201324. https:\/\/doi.org\/10.1038\/nature11582.","journal-title":"Nature"},{"key":"2359_CR65","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, et al. Genome-wide meta-analysis increases to 71 the number of confirmed crohn\u2019s disease susceptibility loci. Nat Genet. 2010;42:1118\u201325. https:\/\/doi.org\/10.1038\/ng.717.","journal-title":"Nat Genet"},{"key":"2359_CR66","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ng.764","volume":"43","author":"CA Anderson","year":"2011","unstructured":"Anderson CA, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43:246\u201352. https:\/\/doi.org\/10.1038\/ng.764.","journal-title":"Nat Genet"},{"key":"2359_CR67","doi-asserted-by":"publisher","unstructured":"Xu P, Becker H, Elizalde M, Masclee A, Jonkers D. Intestinal organoid culture model is a valuable system to study epithelial barrier function in IBD. Gut 67, 1905\u20131906. https:\/\/doi.org\/10.1136\/gutjnl-2017-315685 (2018).","DOI":"10.1136\/gutjnl-2017-315685"},{"key":"2359_CR68","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1101\/gad.227439.113","volume":"27","author":"L Guarente","year":"2013","unstructured":"Guarente L. Calorie restriction and sirtuins revisited. Genes Dev. 2013;27:2072\u201385. https:\/\/doi.org\/10.1101\/gad.227439.113.","journal-title":"Genes Dev"},{"key":"2359_CR69","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.gastro.2017.05.022","volume":"153","author":"AS Wellman","year":"2017","unstructured":"Wellman AS, et al. Intestinal epithelial Sirtuin 1 regulates intestinal inflammation during aging in mice by altering the intestinal microbiota. Gastroenterology. 2017;153:772\u201386. https:\/\/doi.org\/10.1053\/j.gastro.2017.05.022.","journal-title":"Gastroenterology"},{"key":"2359_CR70","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41401-021-00726-0","volume":"43","author":"H-l Li","year":"2021","unstructured":"Li H-l, et al. Diosmetin has therapeutic efficacy in colitis regulating gut microbiota, inflammation, and oxidative stress via the circ-Sirt1\/Sirt1 axis. Acta Pharmacol Sin. 2021;43:919\u201332. https:\/\/doi.org\/10.1038\/s41401-021-00726-0.","journal-title":"Acta Pharmacol Sin"},{"key":"2359_CR71","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1016\/j.apsb.2023.05.031","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Translocation of IGF-1R in Endoplasmic reticulum enhances SERCA2 activity to trigger Ca2\u2009+\u2009ER perturbation in hepatocellular carcinoma. Acta Pharm Sinica B. 2023;13:3744\u201355. https:\/\/doi.org\/10.1016\/j.apsb.2023.05.031.","journal-title":"Acta Pharm Sinica B"},{"key":"2359_CR72","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1161\/circulationaha.122.059863","volume":"145","author":"M Abdellatif","year":"2022","unstructured":"Abdellatif M, et al. Fine-Tuning cardiac Insulin-Like growth factor 1 receptor signaling to promote health and longevity. Circulation. 2022;145:1853\u201366. https:\/\/doi.org\/10.1161\/circulationaha.122.059863.","journal-title":"Circulation"},{"key":"2359_CR73","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1111\/bph.16400","volume":"181","author":"F Sun","year":"2024","unstructured":"Sun F, et al. AdipoRon promotes amyloid-\u03b2 clearance through enhancing autophagy via nuclear GAPDH\u2010induced Sirtuin 1 activation in alzheimer\u2019s disease. Br J Pharmacol. 2024;181:3039\u201363. https:\/\/doi.org\/10.1111\/bph.16400.","journal-title":"Br J Pharmacol"},{"key":"2359_CR74","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s2468-1253(24)00159-6","volume":"9","author":"V Andersen","year":"2024","unstructured":"Andersen V, et al. Sex and gender in inflammatory bowel disease outcomes and research. Lancet Gastroenterol Hepatol. 2024;9:1041\u201351. https:\/\/doi.org\/10.1016\/s2468-1253(24)00159-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2359_CR75","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41575-020-0354-0","volume":"17","author":"WA Goodman","year":"2020","unstructured":"Goodman WA, Erkkila IP, Pizarro TT. Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease. Nat Reviews Gastroenterol Hepatol. 2020;17:740\u201354. https:\/\/doi.org\/10.1038\/s41575-020-0354-0.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"2359_CR76","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","volume":"165","author":"JD Lewis","year":"2023","unstructured":"Lewis JD, et al. Incidence, prevalence, and Racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology. 2023;165:1197\u2013e12051192. https:\/\/doi.org\/10.1053\/j.gastro.2023.07.003.","journal-title":"Gastroenterology"},{"key":"2359_CR77","doi-asserted-by":"publisher","first-page":"126779","DOI":"10.1016\/j.chemosphere.2020.126779","volume":"254","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, et al. Synthesis, insecticidal activity, resistance, photodegradation and toxicity of pyrethroids (A review). Chemosphere. 2020;254:126779. https:\/\/doi.org\/10.1016\/j.chemosphere.2020.126779.","journal-title":"Chemosphere"},{"key":"2359_CR78","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.molp.2023.09.010","volume":"16","author":"C Chen","year":"2023","unstructured":"Chen C, et al. TBtools-II: a one for all, all for one bioinformatics platform for biological big-data mining. Mol Plant. 2023;16:1733\u201342. https:\/\/doi.org\/10.1016\/j.molp.2023.09.010.","journal-title":"Mol Plant"},{"key":"2359_CR79","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.cell.2024.03.036","volume":"187","author":"S Carpenter","year":"2024","unstructured":"Carpenter S, O\u2019Neill LA. J. From periphery to center stage: 50 years of advancements in innate immunity. Cell. 2024;187:2030\u201351. https:\/\/doi.org\/10.1016\/j.cell.2024.03.036.","journal-title":"Cell"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02359-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02359-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02359-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T19:04:41Z","timestamp":1753902281000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02359-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2359"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02359-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Ethics Committee of Peking University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}